Lalchand Bhimraj Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.13 M
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -7.19%
- Profit Growth -8.22%
- Ebitda -11.95%
- Net Worth 23.22%
- Total Assets 20.83%
About Lalchand Bhimraj Pharma
Lalchand Bhimraj Pharma Private Limited (LBPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 March 1992 and has a history of 32 years and ten months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.13 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Bhandari and Dinesh Bhandari serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52599TN1992PTC022406
- Company No.
022406
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Mar 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Lalchand Bhimraj Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Bhandari  | Director | 20-Jun-2002 | Current |
| Dinesh Bhandari | Director | 20-Jun-2002 | Current |
Financial Performance of Lalchand Bhimraj Pharma.
Lalchand Bhimraj Pharma Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.19% decrease. The company also saw a slight decrease in profitability, with a 8.22% decrease in profit. The company's net worth Soared by an impressive increase of 23.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lalchand Bhimraj Pharma?
In 2021, Lalchand Bhimraj Pharma had a public holding of 85.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hibrow Healthcare Private LimitedRajesh Bhandari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lalchand Bhimraj Pharma?
Unlock and access historical data on people associated with Lalchand Bhimraj Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lalchand Bhimraj Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lalchand Bhimraj Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
